4
Changes in Ownership
RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-24-098944
Director sold 20,700 shares at an average $49.71 ($1,028,991)
- Director acquired 20,700 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| TETRAULT LYNN A. Director | 2024-09-09 | Option exercise 10b5-1 | +3,199 | $18.99 | $60,749 | 6,199 | D |
| TETRAULT LYNN A. Director | 2024-09-09 | Sale 10b5-1 | −3,199 | $50.04 | $160,068 | 3,000 | D |
| TETRAULT LYNN A. Director | 2024-09-10 | Option exercise 10b5-1 | +10,000 | $4.15 | $41,500 | 13,000 | D |
| TETRAULT LYNN A. Director | 2024-09-10 | Option exercise 10b5-1 | +7,501 | $18.99 | $142,444 | 20,501 | D |
| TETRAULT LYNN A. Director | 2024-09-10 | Sale 10b5-1 | −8,490 | $49.05 | $416,418 | 12,011 | D |
| TETRAULT LYNN A. Director | 2024-09-10 | Sale 10b5-1 | −8,661 | $50.20 | $434,796 | 3,350 | D |
| TETRAULT LYNN A. Director | 2024-09-10 | Sale 10b5-1 | −350 | $50.60 | $17,710 | 3,000 | D |
| Derivatives | |||||||
| TETRAULT LYNN A. Director | 2024-09-09 | Option exercise · Stock Option (right to buy) 10b5-1 | −3,199 | 7,501 | D | ||
| TETRAULT LYNN A. Director | 2024-09-10 | Option exercise · Stock Option (right to buy) 10b5-1 | −10,000 | 0 | D | ||
| TETRAULT LYNN A. Director | 2024-09-10 | Option exercise · Stock Option (right to buy) 10b5-1 | −7,501 | 0 | D | ||
| Open-market sales · 20,700 sh · avg $49.71 · $1,028,991 | |||||||
Loading xslF345X05/tm2423816-2_4seq1.xml…